387215006: Phenyltoloxamine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Histamine receptor antagonist\Ethanolamine derivative antihistamine\Phenyltoloxamine

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative\Ethanolamine derivative antihistamine\Phenyltoloxamine

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative\Ethanolamine derivative antihistamine\Phenyltoloxamine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Phenyltoloxamine	Is a	Ethanolamine derivative antihistamine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Phenyltoloxamine	Has disposition	Histamine receptor antagonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Phenyltoloxamine measurement	Component	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 2.5mg/5mL 5mg/5mL 7.5mg/5mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Acetaminophen + phenyltoloxamine citrate 500mg/30mg caplets	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorphenamine maleate 4 mg and mepyramine maleate 25 mg and phenylephrine hydrochloride 10 mg and phenylpropanolamine 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing paracetamol and phenyltoloxamine citrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing paracetamol and phenyltoloxamine citrate and salicylamide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing magnesium salicylate and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Phenyltoloxamine citrate	Is a	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Phenyltoloxamine citrate	Is modification of (attribute)	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol- and phenyltoloxamine-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only magnesium salicylate and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only paracetamol and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Paracetamol and phenyltoloxamine and salicylamide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Paracetamol and phenyltoloxamine and salicylamide only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Chlorphenamine and phenylephrine and phenyltoloxamine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing chlorphenamine and phenylephrine and phenyltoloxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing chlorphenamine and phenylephrine and phenyltoloxamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Phenyltoloxamine	Inferred relationship	Existential restriction modifier (core metadata concept)	3

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461393010	Phenyltoloxamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481318014	Phenyltoloxamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461393010	Phenyltoloxamine (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461393010	Phenyltoloxamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481318014	Phenyltoloxamine	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481318014	Phenyltoloxamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
26161000188115	phényltoloxamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
26161000188115	phényltoloxamine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module